University of California, San Diego School of Medicine, La Jolla, CA, USA.
Clinton Health Access Initiative, Boston, MA, USA.
Lancet HIV. 2019 Aug;6(8):e540-e551. doi: 10.1016/S2352-3018(19)30189-4. Epub 2019 Jul 5.
Substantial progress has been made this century in bringing millions of people living with HIV into care, but progress for early HIV diagnosis has stalled. Individuals first diagnosed with advanced HIV have higher rates of mortality than those diagnosed at an earlier stage even after starting antiretroviral therapy (ART), resulting in substantial costs to health systems. Diagnosis of these individuals is hindered because many patients are asymptomatic, despite being severely immunosuppressed. Baseline CD4 counts and screening for opportunistic infections, such as tuberculosis and cryptococcus, is crucial because of the high mortality associated with these co-infections. Individuals with advanced HIV should have rapid ART initiation (except when found to have symptoms, signs, or a diagnosis of cryptococcal meningitis) and those in treatment failure should switch treatment. Overcoming barriers to testing and adherence through the development of differentiated care models and providing psychosocial support will be key in reaching populations at high risk of presenting with advanced HIV.
本世纪在将数百万艾滋病毒感染者纳入护理方面取得了重大进展,但早期艾滋病毒诊断方面的进展已经停滞不前。初次被诊断为晚期艾滋病毒的人,即使在开始抗逆转录病毒治疗 (ART) 后,其死亡率也高于早期诊断的人,这给卫生系统带来了巨大的成本。这些人的诊断受到阻碍,因为尽管免疫抑制严重,但许多患者无症状。由于这些合并感染与高死亡率相关,因此基线 CD4 计数和结核病和隐球菌等机会性感染的筛查至关重要。应迅速开始为晚期艾滋病毒感染者提供 ART(除非发现有症状、体征或隐球菌性脑膜炎的诊断),且治疗失败的患者应更换治疗方案。通过制定差异化护理模式和提供心理社会支持来克服检测和依从性方面的障碍,将是发现高危人群中晚期艾滋病毒的关键。